552 related articles for article (PubMed ID: 10931557)
1. Binding of nascent collagen by amyloidogenic light chains and amyloid fibrillogenesis in monolayers of human fibrocytes.
Harris DL; King E; Ramsland PA; Edmundson AB
J Mol Recognit; 2000; 13(4):198-212. PubMed ID: 10931557
[TBL] [Abstract][Full Text] [Related]
2. Nephrotoxic potential of Bence Jones proteins.
Solomon A; Weiss DT; Kattine AA
N Engl J Med; 1991 Jun; 324(26):1845-51. PubMed ID: 1904132
[TBL] [Abstract][Full Text] [Related]
3. Characterization of amyloidogenic immunoglobulin light chains directly from serum by on-line immunoaffinity isolation.
Bergen HR; Abraham RS; Johnson KL; Bradwell AR; Naylor S
Biomed Chromatogr; 2004 Apr; 18(3):191-201. PubMed ID: 15103706
[TBL] [Abstract][Full Text] [Related]
4. Bence Jones proteins and light chains of immunoglobulins. XIII. Effect of elastase-like and chymotrypsin-like neutral proteases derived from human granulocytes on Bence Jones proteins.
Solomon A; Schmidt W; Havemann K
J Immunol; 1976 Sep; 117(3):1010-4. PubMed ID: 60445
[TBL] [Abstract][Full Text] [Related]
5. Interaction between glycosaminoglycans and immunoglobulin light chains.
Jiang X; Myatt E; Lykos P; Stevens FJ
Biochemistry; 1997 Oct; 36(43):13187-94. PubMed ID: 9341206
[TBL] [Abstract][Full Text] [Related]
6. Review: immunoglobulin light chain amyloidosis--the archetype of structural and pathogenic variability.
Bellotti V; Mangione P; Merlini G
J Struct Biol; 2000 Jun; 130(2-3):280-9. PubMed ID: 10940232
[TBL] [Abstract][Full Text] [Related]
7. Current concepts of the formation and composition of amyloid.
Glenner GG
Ann Clin Lab Sci; 1975; 5(4):257-63. PubMed ID: 808999
[TBL] [Abstract][Full Text] [Related]
8. Structural relationship of lambda-type light chains with AL amyloidosis.
Alim MA; Yamaki S; Hossain MS; Takeda K; Yamagata F; Takashi I; Shinoda T
Clin Immunol; 1999 Mar; 90(3):399-403. PubMed ID: 10075869
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis, diagnosis and treatment of systemic amyloidosis.
Pepys MB
Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):203-10; discussion 210-1. PubMed ID: 11260801
[TBL] [Abstract][Full Text] [Related]
10. Immunogold quantitation of immunoglobulin light chains in renal amyloidosis and kappa light chain nephropathy.
Silver MM; Hearn SA; Walton JC; Lines LA; Walley VM
Am J Pathol; 1990 May; 136(5):997-1007. PubMed ID: 1693473
[TBL] [Abstract][Full Text] [Related]
11. A single mutation at the sheet switch region results in conformational changes favoring lambda6 light-chain fibrillogenesis.
Hernández-Santoyo A; del Pozo Yauner L; Fuentes-Silva D; Ortiz E; Rudiño-Piñera E; Sánchez-López R; Horjales E; Becerril B; Rodríguez-Romero A
J Mol Biol; 2010 Feb; 396(2):280-92. PubMed ID: 19941869
[TBL] [Abstract][Full Text] [Related]
12. Primary structure of the variable region of a human lambda VI light chain: Bence Jones protein SUT.
Frangione B; Moloshok T; Solomon A
J Immunol; 1983 Nov; 131(5):2490-3. PubMed ID: 6415173
[TBL] [Abstract][Full Text] [Related]
13. A case of primary immunoglobulin light chain amyloidosis with a delayed appearance of Bence Jones protein in urine.
Kurusu A; Yamada T; Yamaji K; Nishitani M; Tashiro K; Maeda K; Horikoshi S; Shirato I; Rinno H; Tomino Y
Nephrology (Carlton); 2004 Jun; 9(3):122-5. PubMed ID: 15189172
[TBL] [Abstract][Full Text] [Related]
14. Mcg in 2030: new techniques for atomic position determination of immune complexes.
Hanson BL; Bunick GJ; Harp JM; Edmundson AB
J Mol Recognit; 2002; 15(5):297-305. PubMed ID: 12447907
[TBL] [Abstract][Full Text] [Related]
15. A glycosylated Bence Jones protein and its autologous amyloid light chain containing potentially amyloidogenic residues.
Foss GS; Nilsen R; Cornwell GC; Husby G; Sletten K
Scand J Immunol; 1998 Apr; 47(4):348-54. PubMed ID: 9600316
[TBL] [Abstract][Full Text] [Related]
16. Extracellular matrix regulates the amount of the beta-amyloid precursor protein and its amyloidogenic fragments.
Bronfman FC; Soto C; Tapia L; Tapia V; Inestrosa NC
J Cell Physiol; 1996 Feb; 166(2):360-9. PubMed ID: 8591996
[TBL] [Abstract][Full Text] [Related]
17. [Amyloidosis of the A-kappa type].
Scherwitz C; Linke RP; Schmitt FJ
Hautarzt; 1986 Jun; 37(6):343-6. PubMed ID: 3087912
[TBL] [Abstract][Full Text] [Related]
18. Glomerulopathic light chain-mesangial cell interactions modulate in vitro extracellular matrix remodeling and reproduce mesangiopathic findings documented in vivo.
Herrera GA; Russell WJ; Isaac J; Turbat-Herrera EA; Tagouri YM; Sanders PW; Picken MM; Dempsey S
Ultrastruct Pathol; 1999; 23(2):107-26. PubMed ID: 10369104
[TBL] [Abstract][Full Text] [Related]
19. Principles and pitfalls in designing site-directed peptide ligands.
Edmundson AB; Harris DL; Fan ZC; Guddat LW; Schley BT; Hanson BL; Tribbick G; Geysen HM
Proteins; 1993 Jul; 16(3):246-67. PubMed ID: 8346191
[TBL] [Abstract][Full Text] [Related]
20. [M-component of serum formed by lambda-type Bence-Jones protein].
Snigurowicz J; Rostkowska J; Powiertowska-Rezmer M
Acta Haematol Pol; 1976; 7(2):103-9. PubMed ID: 820159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
